Skip to main content

Illumina income statement

  • ILMN · Nasdaq
  • Instruments
  • Life Sciences Tools & Services
  • S&P 500
$198.26−4.22%Close 16 Nov 2026 · Market value $30.43B

Illumina reported revenue of $4.34 billion for fiscal year 2025 (the twelve months to 28 Dec 2025), down 0.7% from fiscal 2024. Net income was $850 million and diluted earnings per share $5.45.

From Illumina's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 28 Dec 2025. TTM is the last four reported quarters added up.

Annual

Illumina income statement, annual
USDFY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Revenue$573.2M$666.3M$902.7M$1.06B$1.15B$1.42B$1.86B$2.22B$2.40B$2.75B$3.33B$3.54B$3.24B$4.53B$4.58B$4.50B$4.37B$4.34B$4.54B
Revenue growth—+16.2%+35.5%+16.9%+8.8%+23.7%+31.0%+19.3%+8.0%+14.8%+21.1%+6.3%−8.6%+39.7%+1.3%−1.7%−2.9%−0.7%—
Cost of revenue$220.1M$212.4M$301.2M$346.4M$375.0M$509.3M$563.6M$671.0M$732.0M$926.0M$1.03B$1.08B$1.04B$1.37B$1.61B$1.76B$1.51B$1.47B$1.46B
Gross profit$353.1M$453.9M$601.5M$709.1M$773.5M$911.9M$1.30B$1.55B$1.67B$1.83B$2.30B$2.47B$2.20B$3.15B$2.97B$2.74B$2.86B$2.87B$3.08B
Gross margin61.6%68.1%66.6%67.2%67.4%64.2%69.7%69.8%69.5%66.4%69.0%69.6%68.0%69.7%64.8%60.9%65.4%66.1%67.9%
Research and development$99.96M$140.6M$177.9M$196.9M$231.0M$276.7M$388.1M$401.0M$504.0M$546.0M$623.0M$647.0M$682.0M$1.19B$1.32B$1.35B$1.17B$967.0M$975.0M
Selling, general and administrative$148.0M$176.3M$220.5M$261.8M$286.0M$381.0M$466.3M$516.0M$584.0M$674.0M$794.0M$835.0M$941.0M$2.09B$1.30B$1.61B$1.09B$1.09B$1.14B
Operating expenses$272.6M$328.3M$389.9M$509.6M$572.8M$777.8M$783.0M$936.0M$1.08B$1.22B$1.42B$1.48B$1.62B$3.28B$7.15B$3.81B$3.69B$2.06B$2.12B
Operating income$80.46M$125.6M$211.7M$199.5M$200.8M$134.1M$514.7M$613.0M$587.0M$606.0M$883.0M$985.0M$580.0M−$123.0M−$4.18B−$1.07B−$833.0M$807.0M$960.0M
Operating margin14.0%18.8%23.4%18.9%17.5%9.4%27.7%27.6%24.5%22.0%26.5%27.8%17.9%−2.7%−91.2%−23.7%−19.1%18.6%21.2%
Interest expense$22.21M$23.72M$24.60M$34.79M$37.78M$39.69M$41.73M$43.00M$33.00M$37.00M$57.00M$52.00M$49.00M$61.00M$26.00M$77.00M$100.0M$101.0M$97.00M
Other income and expense−$7.77M−$11.47M−$26.27M−$66.42M$21.86M$25.21M−$65.95M−$30.00M−$26.00M$437.0M$11.00M$133.0M$276.0M$1.01B−$157.0M−$48.00M−$346.0M$279.0M$98.00M
Income before tax$72.69M$114.1M$185.4M$133.0M$222.6M$159.3M$448.8M$583.0M$561.0M$1.04B$894.0M$1.12B$856.0M$884.0M−$4.34B−$1.12B−$1.18B$1.09B$1.06B
Income tax expense$33.27M$41.84M$60.49M$46.42M$71.35M$34.01M$95.41M$125.0M$133.0M$365.0M$112.0M$128.0M$200.0M$122.0M$68.00M$44.00M$44.00M$236.0M$163.0M
Effective tax rate45.8%36.7%32.6%34.9%32.1%21.3%21.3%21.4%23.7%35.0%12.5%11.4%23.4%13.8%−1.6%−3.9%−3.7%21.7%15.4%
Net income$39.42M$72.28M$124.9M$86.63M$151.3M$125.3M$353.4M$462.0M$463.0M$726.0M$826.0M$1.00B$656.0M$762.0M−$4.40B−$1.16B−$1.22B$850.0M$895.0M
Net margin6.9%10.8%13.8%8.2%13.2%8.8%19.0%20.8%19.3%26.4%24.8%28.3%20.3%16.8%−96.1%−25.8%−28.0%19.6%19.7%
EPS · diluted$0.30$0.53$0.87$0.62$1.13$0.90$2.37$3.10$3.07$4.92$5.56$6.74$4.45$5.04−$28.00−$7.34−$7.69$5.45$5.83
Diluted weighted average shares134M137M143M139M134M140M149M149M148M148M149M149M148M151M157M158M159M156M154M
Basic weighted average shares117M123M124M123M123M125M136M145M147M146M147M147M147M150M157M158M159M155M152M
EBITDA$108.2M$156.8M$253.7M$268.7M$266.1M$232.0M$627.3M$740.0M$728.0M$762.0M$1.06B$1.17B$767.0M$128.0M−$3.79B−$637.0M−$479.0M$1.08B$1.24B
EBITDA margin18.9%23.5%28.1%25.5%23.2%16.3%33.7%33.3%30.4%27.7%31.9%33.1%23.7%2.8%−82.6%−14.1%−11.0%24.8%27.3%
Depreciation & amortization$27.72M$31.18M$42.00M$69.19M$65.32M$97.92M$112.6M$127.0M$141.0M$156.0M$179.0M$188.0M$187.0M$251.0M$394.0M$432.0M$354.0M$270.0M$277.0M
Stock-based compensation$47.69M$60.81M$71.64M$92.09M$94.32M$105.8M$152.6M$133.0M$129.0M$164.0M$193.0M$194.0M$194.0M$754.0M$366.0M$380.0M$370.0M$275.0M$270.0M

Quarterly

Illumina income statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$1.12B$1.08B$1.11B$1.08B$1.10B$1.04B$1.06B$1.08B$1.16B$1.09B$1.16B$1.13B
Cost of revenue$448.0M$409.0M$391.0M$335.0M$376.0M$358.0M$364.0M$351.0M$400.0M$370.0M$389.0M$299.0M
Gross profit$674.0M$667.0M$721.0M$745.0M$728.0M$683.0M$695.0M$733.0M$759.0M$721.0M$770.0M$830.0M
Gross margin60.1%62.0%64.8%69.0%65.9%65.6%65.6%67.6%65.5%66.1%66.4%73.5%
Research and development$341.0M$339.0M$325.0M$253.0M$256.0M$252.0M$247.0M$229.0M$239.0M$240.0M$252.0M$244.0M
Selling, general and administrative$485.0M$439.0M$147.0M$239.0M$279.0M$267.0M$234.0M$277.0M$309.0M$272.0M$273.0M$281.0M
Operating expenses$838.0M$778.0M$2.36B$4.00M$553.0M$519.0M$481.0M$506.0M$558.0M$512.0M$525.0M$525.0M
Operating income−$164.0M−$111.0M−$1.64B$741.0M$175.0M$164.0M$214.0M$227.0M$201.0M$209.0M$245.0M$305.0M
Operating margin−14.6%−10.3%−147%68.6%15.9%15.8%20.2%20.9%17.3%19.2%21.1%27.0%
Interest expense$18.00M$18.00M$20.00M$36.00M$25.00M$25.00M$25.00M$25.00M$26.00M$24.00M$23.00M$24.00M
Other income and expense−$3.00M$2.00M−$339.0M−$21.00M$12.00M$18.00M$92.00M−$7.00M$176.0M−$52.00M$15.00M−$41.00M
Income before tax−$167.0M−$109.0M−$1.98B$720.0M$187.0M$182.0M$306.0M$220.0M$377.0M$157.0M$260.0M$264.0M
Income tax expense$8.00M$17.00M$12.00M$15.00M$0.00$51.00M$71.00M$70.00M$43.00M$23.00M$53.00M$44.00M
Effective tax rate−4.8%−15.6%−0.6%2.1%0.0%28.0%23.2%31.8%11.4%14.6%20.4%16.7%
Net income−$176.0M−$126.0M−$1.99B$705.0M$186.0M$131.0M$235.0M$150.0M$334.0M$134.0M$207.0M$220.0M
Net margin−15.7%−11.7%−179%65.3%16.8%12.6%22.2%13.8%28.8%12.3%17.9%19.5%
EPS · diluted−$1.11−$0.79−$12.48$4.42$1.17$0.82$1.49$0.98$2.18$0.87$1.35$1.43
Diluted weighted average shares158M159M159M160M159M159M157M154M153M154M153M154M
Basic weighted average shares158M159M159M159M159M159M157M153M152M153M151M151M
EBITDA−$55.00M−$3.00M−$1.53B$811.0M$246.0M$233.0M$282.0M$294.0M$267.0M$278.0M$315.0M$377.0M
EBITDA margin−4.9%−0.3%−138%75.1%22.3%22.4%26.6%27.1%23.0%25.5%27.2%33.4%
Depreciation & amortization$109.0M$108.0M$105.0M$70.00M$71.00M$69.00M$68.00M$67.00M$66.00M$69.00M$70.00M$72.00M
Stock-based compensation$94.00M$96.00M$112.0M$83.00M$79.00M$73.00M$69.00M$70.00M$63.00M$60.00M$73.00M$74.00M

The main figures as JSON and plain text. See data and methodology.

ILMN in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.